Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique Platform

Inhibrx Biosciences (NASDAQ: INBX ) is a spinoff from "old" Inhibrx, funded by a merger with a Sanofi subsidiary back in May of 2024. They have 2 pipeline candidates that we're going to learn about today, in addition toI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfal ...